High glucose induces HGF-independent activation of Met receptor in human renal tubular epithelium

References

• Remuzzi G, Schieppati A, Ruggenenti P. Clinical practice. Nephropathy in patients with type 2 diabetes. N Engl J Med. 2002;346:1145–1151.
   PubMed Web of Science ®Google Scholar
• Mason RM, Wahab NA. Extracellular matrix metabolism in diabetic nephropathy. J Am Soc Nephrol. 2003;14:1358–1373.
   PubMed Web of Science ®Google Scholar
• Parving HH, Tarnow L, Rossing P. Genetics of diabetic nephropathy. J Am Soc Nephrol. 1996;7:2509–2517.
   PubMed Web of Science ®Google Scholar
• Kiencke S, Handschin R, von Dahlen R, et al. Pre-clinical diabetic cardiomyopathy: prevalence, screening, and outcome. Eur J Heart Fail. 2010;12:951–957.
   PubMed Web of Science ®Google Scholar
• Weidner KM, Arakaki N, Hartmann G, et al. Evidence for the identity of human scatter factor and human hepatocyte growth factor. Proc Natl Acad Sci USA. 1991;88:7001–7005.
   PubMed Web of Science ®Google Scholar
• Nakamura T, Nishizawa T, Hagiya M, et al. Molecular cloning and expression of human hepatocyte growth factor. Nature. 1989;342:440–443.
   PubMed Web of Science ®Google Scholar
• Stoker M, Gherardi E, Perryman M, et al. Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature. 1987;327:239–242.
   PubMed Web of Science ®Google Scholar
• Matsumoto K, Nakamura T. Hepatocyte growth factor: renotropic role and potential therapeutics for renal diseases. Kidney Int. 2001;59:2023–2038.
   PubMed Web of Science ®Google Scholar
• Liu Y, Yang J. Hepatocyte growth factor: new arsenal in the fights against renal fibrosis? Kidney Int. 2006;70:238–240.
   PubMed Web of Science ®Google Scholar
• Okada H, Kalluri R. Cellular and molecular pathways that lead to progression and regression of renal fibrogenesis. Curr Mol Med. 2005;5:467–474.
   PubMed Web of Science ®Google Scholar
• Wang S-N, Hirschberg R. Growth factor ultrafiltration in experimental diabetic nephropathy contributes to interstitial fibrosis. Am J Physiol-Ren Physiol. 2000;278:F554–F560.
   PubMed Web of Science ®Google Scholar
• Comoglio PM, Giordano S, Trusolino L. Drug development of MET inhibitors: targeting oncogene addiction and expedience. Nat Rev Drug Discov. 2008;7:504–516.
   PubMed Web of Science ®Google Scholar
• Organ SL, Tsao M-S. An overview of the c-MET signaling pathway. Ther Adv Med Oncol. 2011;3:S7–S19.
   PubMedGoogle Scholar
• Falk RJ, Scheinman JI, Mauer SM, et al. Polyantigenic expansion of basement membrane constituents in diabetic nephropathy. Diabetes. 1983;32 Suppl 2:34–39.
   PubMed Web of Science ®Google Scholar
• Steffes MW, Brown DM, Basgen JM, et al. Glomerular basement membrane thickness following islet transplantation in the diabetic rat. Lab Investig J Tech Methods Pathol. 1979;41:116–118.
   PubMed Web of Science ®Google Scholar
• Chan P-C, Chen S-Y, Chen C-H, et al. Crosstalk between hepatocyte growth factor and integrin signaling pathways. J Biomed Sci. 2006;13:215–223.
   PubMed Web of Science ®Google Scholar
• Wang R, Kobayashi R, Bishop JM. Cellular adherence elicits ligand-independent activation of the Met cell-surface receptor. Proc Natl Acad Sci USA. 1996;93:8425–8430.
   PubMed Web of Science ®Google Scholar
• Roy S, Sala R, Cagliero E, et al. Overexpression of fibronectin induced by diabetes or high glucose: phenomenon with a memory. Proc Natl Acad Sci USA. 1990;87:404–408.
   PubMed Web of Science ®Google Scholar
• Presnell SC, Stolz DB, Mars WM, et al. Modifications of the hepatocyte growth factor/c-met pathway by constitutive expression of transforming growth factor-alpha in rat liver epithelial cells. Mol Carcinog. 1997;18:244–255.
   PubMed Web of Science ®Google Scholar
• Nakamura T, Nawa K, Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun. 1984;122:1450–1459.
   PubMed Web of Science ®Google Scholar
• Nakamura T. Structure and function of hepatocyte growth factor. Prog Growth Factor Res. 1991;3:67–85.
   PubMedGoogle Scholar
• Jo M, Stolz DB, Esplen JE, et al. Cross-talk between epidermal growth factor receptor and c-Met signal pathways in transformed cells. J Biol Chem. 2000;275:8806–8811.
   PubMed Web of Science ®Google Scholar
• Mimura Y, Ihn H, Jinnin M, et al. Epidermal growth factor induces fibronectin expression in human dermal fibroblasts via protein kinase C delta signaling pathway. J Invest Dermatol. 2004;122:1390–1398.
   PubMed Web of Science ®Google Scholar
• Kawaida K, Matsumoto K, Shimazu H, et al. Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice. Proc Natl Acad Sci USA. 1994;91:4357–4361.
   PubMed Web of Science ®Google Scholar
• Dai C, Yang J, Liu Y. Single injection of naked plasmid encoding hepatocyte growth factor prevents cell death and ameliorates acute renal failure in mice. J Am Soc Nephrol. 2002;13:411–422.
   PubMed Web of Science ®Google Scholar
• Rodrigues GA, Park M. Autophosphorylation modulates the kinase activity and oncogenic potential of the Met receptor tyrosine kinase. Oncogene. 1994;9:2019–2027.
   PubMed Web of Science ®Google Scholar
• Graziani A, Gramaglia D, dalla Zonca P, et al. Hepatocyte growth factor/scatter factor stimulates the Ras-guanine nucleotide exchanger. J Biol Chem. 1993;268:9165–9168.
   PubMed Web of Science ®Google Scholar
• Xiao GH, Jeffers M, Bellacosa A, et al. Anti-apoptotic signaling by hepatocyte growth factor/Met via the phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways. Proc Natl Acad Sci USA. 2001;98:247–252.
   PubMed Web of Science ®Google Scholar
• Boccaccio C, Andò M, Tamagnone L, et al. Induction of epithelial tubules by growth factor HGF depends on the STAT pathway. Nature. 1998;391:285–288.
   PubMed Web of Science ®Google Scholar
• Syed ZA, Yin W, Hughes K, et al. HGF/c-met/Stat3 signaling during skin tumor cell invasion: indications for a positive feedback loop. BMC Cancer. 2011;11:180.
   PubMed Web of Science ®Google Scholar
• Zou HY, Li Q, Lee JH, et al. An orally available small-molecule inhibitor of c-Met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms. Cancer Res. 2007;67:4408–4417.
   PubMed Web of Science ®Google Scholar
• Christensen JG, Zou HY, Arango ME, et al. Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma. Mol Cancer Ther. 2007;6:3314–3322.
   PubMed Web of Science ®Google Scholar
• Dixon AJ, Burns J, Dunnill MS, et al. Distribution of fibronectin in normal and diseased human kidneys. J Clin Pathol. 1980;33:1021–1028.
   PubMed Web of Science ®Google Scholar
• Weiss MA, Ooi BS, Ooi YM, et al. Immunofluorescent localization of fibronectin in the human kidney. Lab Invest. 1979;41:340–347.
   PubMed Web of Science ®Google Scholar
• Miller CG, Pozzi A, Zent R, et al. Effects of high glucose on integrin activity and fibronectin matrix assembly by mesangial cells. Mol Biol Cell. 2014;25:2342–2350.
   PubMed Web of Science ®Google Scholar
• Kerjaschki D, Ojha PP, Susani M, et al. A beta 1-integrin receptor for fibronectin in human kidney glomeruli. Am J Pathol. 1989;134:481–489.
   PubMed Web of Science ®Google Scholar
• Kagami S, Border WA, Ruoslahti E, et al. Coordinated expression of beta 1 integrins and transforming growth factor-beta-induced matrix proteins in glomerulonephritis. Lab Investig J Tech Methods Pathol. 1993;69:68–76.
   PubMed Web of Science ®Google Scholar
• Ban CR, Twigg SM. Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markers. VHRM. 2008;4:575–596.
   Google Scholar
• Sugimoto H, Shikata K, Hirata K, et al. Increased expression of intercellular adhesion molecule-1 (ICAM-1) in diabetic rat glomeruli: glomerular hyperfiltration is a potential mechanism of ICAM-1 upregulation. Diabetes. 1997;46:2075–2081.
   PubMed Web of Science ®Google Scholar
• Zhao X, Zhang Y, Li L, et al. Glomerular expression of kidney injury molecule-1 and podocytopenia in diabetic glomerulopathy. Am J Nephrol. 2011;34:268–280.
   PubMed Web of Science ®Google Scholar
• Habib SL. Diabetes and renal tubular cell apoptosis. World J Diabetes. 2013;4:27–30.
   PubMedGoogle Scholar
• Nagaike M, Hirao S, Tajima H, et al. Renotropic functions of hepatocyte growth factor in renal regeneration after unilateral nephrectomy. J Biol Chem. 1991;266:22781–22784.
   PubMed Web of Science ®Google Scholar
• Liu Y, Tolbert EM, Lin L, et al. Up-regulation of hepatocyte growth factor receptor: an amplification and targeting mechanism for hepatocyte growth factor action in acute renal failure. Kidney Int. 1999;55:442–453.
   PubMed Web of Science ®Google Scholar
• Flaquer M, Franquesa M, Vidal A, et al. Hepatocyte growth factor gene therapy enhances infiltration of macrophages and may induce kidney repair in db/db mice as a model of diabetes. Diabetologia. 2012;55:2059–2068.
   PubMed Web of Science ®Google Scholar